• You must be logged in to see or use the Shoutbox. Besides, if you haven't registered, you really should. It's quick and it will make your life a little better. Trust me. So just register and make yourself at home with like-minded individuals who share either your morbid curiousity or sense of gallows humor.
My feelings about this are very conflicted since where is the personal responsibility of the people that chose to abuse pain killers and went on to other drugs when they were cut off.

When I was in the hospital for pancreatitis I did not take any pain medication and just slept the entire time.

The same with the kidney stones and after my surgeries I never took any pain medication.

My concern is that if some get their way and all drugs are legalized will the tax payers be on the hook when the meth head says the government got them hooked on the drug.
 

Yes! Yes! Yes!

Judge rejects Purdue Pharma’s sweeping opioid settlement​

A federal judge rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic Thursday because of a provision that would protect members of the Sackler family from facing litigation of their own.

U.S. District Judge Colleen McMahon in New York found that federal bankruptcy law does not give the bankruptcy judge who had accepted the plan the authority to grant that kind of release for people who are not declaring bankruptcy themselves.

In a statement Thursday night, the company said that it would appeal the ruling and at the same time try to forge another plan that its creditors will agree to.

Purdue said the ruling will not hurt the company’s operations, but it will make it harder for company and Sackler money to be used to fight the opioid crisis as the legal fight continues.
 
Last edited:

Purdue Pharma, US states agree to new opioid settlement​

OxyContin maker Purdue Pharma reached a settlement Thursday over its role in the opioid crisis that includes virtually all U.S. states and thousands of local governments, with the Sackler family members who own the company boosting their cash contribution to as much as $6 billion.

The deal follows an earlier settlement that had been appealed by eight states and the District of Columbia. They agreed to sign on after the Sacklers kicked in more cash — including a portion that just those jurisdictions would control — and accepted other terms. In exchange, the family would be protected from civil lawsuits.

In all, the plan could be more than $10 billion over time. It calls for members of the Sackler family to give up control of the Stamford, Connecticut-based company so it can be turned into a new entity with profits used to fight the crisis. The deal would not shield members of the family from criminal charges, though there’s no indication any are forthcoming.

Sackler family members have not unequivocally offered an apology, though they issued a new statement of regret about the toll of OxyContin. And victims are to have a forum, by videoconference, in court to address Sackler family members — something they have not been able to do in a public setting.

The settlement, outlined in a report filed in U.S. Bankruptcy Court in White Plains, New York, still must be approved by a judge.

“The Sackler families are pleased to have reached a settlement with additional states that will allow very substantial additional resources to reach people and communities in need," the family statement reads. "The families have consistently affirmed that settlement is by far the best way to help solve a serious and complex public health crisis. While the families have acted lawfully in all respects, they sincerely regret that OxyContin, a prescription medicine that continues to help people suffering from chronic pain, unexpectedly became part of an opioid crisis that has brought grief and loss to far too many families and communities.”
 

Opioid crisis victims to confront Purdue Pharma’s owners​

NEW YORK (AP) — Releasing years of anguish and anger, victims of opioid abuse and those who have lost loved ones to an addiction crisis stretching back more than two decades unloaded their emotions on members of the family they blame for fueling the deadly epidemic.

Thursday’s unusual hearing, conducted virtually in U.S. Bankruptcy Court, gave them what they have wanted for years: the chance to confront members of the Sackler family who own OxyContin maker Purdue Pharma and tell them about the lasting pain that addiction and overdoses have had in their lives.

“When you created OxyContin, you created so much loss for so many people. ... I’m outraged that you haven’t owned up to the crisis that you’ve created,” said Kay Scarpone, addressing the three Sackler family members in attendance. She lost her son Joseph Scarpone, a former marine, to addiction a month before his 26th birthday.
 
This is a never ending nightmare and will continue to only grow .. it’s create tremendous hardships on people like me and others that need the medication and depend on it to live normal functioning lives and who don’t abuse it .. I wish they could drain them from every penny they’ve ever made and confiscate everything they’ve ever owned and drain the shell companies they’ve created to hide billions .. if not trillions of dollars .. these people have lost their lives .. their lively hood .. their families and so much that can never be replaced ..
 
Last edited:

Supreme Court blocks, for now, OxyContin maker’s bankruptcy deal that would shield Sackler family members​

WASHINGTON (AP) — The Supreme Court on Thursday temporarily blocked a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices agreed to a request from the Biden administration to put the brakes on an agreement reached last year with state and local governments. In addition, the high court will hear arguments before the end of the year over whether the settlement can proceed.

The deal would allow the company to emerge from bankruptcy as a different entity, with its profits used to fight the opioid epidemic. Members of the Sackler family would contribute up to $6 billion.

But a key component of the agreement would shield family members, who are not seeking bankruptcy protection as individuals, from lawsuits.

The U.S. Bankruptcy Trustee, represented by the Justice Department, opposes releasing the Sackler family from legal liability.

The justices directed the parties to address whether bankruptcy law authorizes a blanket shield from lawsuits filed by all opioid victims.

The 2nd U.S. Circuit Court of Appeals had allowed the reorganization plan to proceed.

Lawyers for Purdue and other parties to the agreement had urged the justices to stay out of the case.
 

The Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake​

WASHINGTON (AP) — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

The high court put the settlement on hold during the summer, in response to objections from the Biden administration.
 

Supreme Court rejects nationwide opioid settlement with OxyContin maker Purdue Pharma​

The Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil lawsuits over the toll of opioids but also would have provided billions of dollars to combat the opioid epidemic.

After deliberating more than six months, the justices in a 5-4 vote blocked an agreement hammered out with state and local governments and victims. The Sacklers would have contributed up to $6 billion and given up ownership of the company but retained billions more. The agreement provided that the company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

Justice Neil Gorsuch, writing for the majority, said “nothing in present law authorizes the Sackler discharge.”

Justices Brett Kavanaugh, Ketanji Brown Jackson, Elena Kagan and Sonia Sotomayor dissented.
 

Purdue Pharma, Sackler family owners agree to landmark $7.4B opioid settlement​

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication Oxycontin caused a widespread opioid addiction crisis in the US, Texas attorney general Ken Paxton said Thursday.

The settlement was announced nearly seven months after the US Supreme Court upended the company’s previous attempt to resolve the lawsuits in a bankruptcy settlement that would have granted the Sacklers sweeping civil immunity from opioid lawsuits in exchange for a payment of up to $6 billion.

The Supreme Court ruled that the Sacklers, who did not file for bankruptcy themselves, were not entitled to legal protections meant to give bankrupt debtors a “fresh start.”
 
Back
Top